InvestorsHub Logo
Followers 0
Posts 106
Boards Moderated 0
Alias Born 05/04/2022

Re: TTsr post# 687437

Friday, 04/26/2024 7:58:58 PM

Friday, April 26, 2024 7:58:58 PM

Post# of 689613
I understand the financial constraints and respect your point and to be completely fair the cell therapy landscape has changed so much since this company started. I think it’s more wishful thinking because there are a lot of early stage companies with promising technology that have obtained very strong business development relationships for funding. look at Arcellx and Gilead.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News